🕵️ Globus Medical Inc ($GMED)
SEC insider & ownership activity, last 12 months · CIK 1237831 · every row links its SEC filing
Over the last 12 months insiders sold $13.7M with no open-market buying against it. David D. Davidar sold $4.2M in discretionary trades (Nov–Jun). Blackrock, Inc. added 7.8% → 9.1%; Janus Henderson Group PLC added 5.8% → 6.1%. No red-flag 8-Ks in the window.
🚨 1 signal active —
planned-vs-executed verdicts, pre-event flags, and cluster context live in the
API and the
alerts bot.
Monthly net open-market insider flow, last 12 months (up = net buying)
Insider flow
0 buyers, $0 (0 lots) · 6 sellers, $13.7M (13 lots)
| Insider | Buys | Bought | Sells | Sold | Last |
|---|---|---|---|---|---|
| David D. Davidar | 0 | – | 2 | $4.2M | Jun 5, 2026 |
| Huller Kelly | 0 | – | 3 | $3.4M | Feb 25, 2026 |
| Stephen T. Zarrilli | 0 | – | 1 | $2.1M | Nov 11, 2025 |
| Kline Kyle | 0 | – | 2 | $2.0M | Jan 8, 2026 |
| Ann D. Rhoads | 0 | – | 3 | $1.4M | Nov 10, 2025 |
| Leslie V. Norwalk | 0 | – | 2 | $558K | Jan 8, 2026 |
5%+ holders
| Holder | Stake | Class | Schedule | Event | |
|---|---|---|---|---|---|
| Blackrock, Inc. | 9.1% | 13G | Apr 24, 2025 | filing ↗ | |
| Janus Henderson Group PLC | 6.1% | 13G | May 14, 2025 | filing ↗ | |
| Vanguard Capital Management | 5.2% | 13G | Apr 30, 2026 | filing ↗ |
Planned insider sales (Form 144)
| Seller | Planned | Approx. sale date | |
|---|---|---|---|
| David D. Davidar | $2.0M | Jun 5, 2026 | filing ↗ |
| John A. Deford | $2.8M | Apr 14, 2026 | filing ↗ |
| Huller Kelly | $1.9M | Feb 25, 2026 | filing ↗ |
| Huller Kelly | $876K | Feb 12, 2026 | filing ↗ |
| Kline Kyle | $363K | Jan 8, 2026 | filing ↗ |
| Leslie V. Norwalk | $202K | Jan 8, 2026 | filing ↗ |
| Leslie V. Norwalk | $355K | Dec 12, 2025 | filing ↗ |
| Kline Kyle | $1.7M | Dec 1, 2025 | filing ↗ |
| Huller Kelly | $675K | Nov 25, 2025 | filing ↗ |
| David D. Davidar | $2.1M | Nov 12, 2025 | filing ↗ |
| Stephen T. Zarrilli | $2.1M | Nov 11, 2025 | filing ↗ |
| Ann D. Rhoads | $170K | Nov 10, 2025 | filing ↗ |
| Ann D. Rhoads | $648K | Nov 7, 2025 | filing ↗ |
| Ann D. Rhoads | $584K | Sep 15, 2025 | filing ↗ |
Material events (8-K)
| Item | Event date | |
|---|---|---|
| Officer/director changes (5.02) | Jun 3, 2026 | filing ↗ |
| Shareholder vote (5.07) | Jun 3, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Jun 3, 2026 | filing ↗ |
| Earnings (2.02) | May 7, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | May 7, 2026 | filing ↗ |
| Officer/director changes (5.02) | Mar 23, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | Mar 23, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Mar 23, 2026 | filing ↗ |
| Earnings (2.02) | Feb 24, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Feb 24, 2026 | filing ↗ |
| Earnings (2.02) | Jan 7, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Jan 7, 2026 | filing ↗ |
| Earnings (2.02) | Nov 6, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Nov 6, 2025 | filing ↗ |
| Earnings (2.02) | Aug 7, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Aug 7, 2025 | filing ↗ |